Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 21Carcinoma, Non-Small-Cell Lung 12Rectal Neoplasms 9Glioblastoma 9Esophageal Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Stomach Neoplasms 7Pancreatic Neoplasms 7Lung Neoplasms 6Head and Neck Neoplasms 6Colorectal Neoplasms 5Sarcoma 4Ovarian Neoplasms 4Neoplasms 4Fallopian Tube Neoplasms 4Colonic Neoplasms 3Brain Neoplasms 3Adenocarcinoma of Lung 3Urinary Bladder Neoplasms 2Osteosarcoma 2Melanoma 2Glioma 2Carcinoma, Ovarian Epithelial 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma 2Adenocarcinoma Of Esophagus 2Xerostomia 1Wilms Tumor 1Urethral Neoplasms 1Triple Negative Breast Neoplasms 1

Interventions

aldesleukin 15Cyclophosphamide 15fludarabine phosphate 12fludarabine 11Interleukin-2 10Nivolumab 6Ipilimumab 6Temozolomide 5pembrolizumab 3Fluorouracil 3trametinib 2sonidegib 2dabrafenib 2binimetinib 2Whole-Body Irradiation 2Vemurafenib 2Tacrolimus 2Sodium Chloride 2Sirolimus 2Radiotherapy 2Radiation 2Peptides 2HhAntag691 2Gefitinib 2Dacarbazine 2Cyclosporine 2Cetuximab 2Capecitabine 2veliparib 1varlilumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Skin Neoplasms × Surgical Procedures, Operative × Clear all
NCT00126555 2019-08-30

Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer

National Cancer Institute (NCI)

Phase 2 Completed
23 enrolled 12 charts
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡